Dose Escalation and Dose Expansion Study of MDX2001 in Patients With Advanced Solid Tumors
Status: NOT_YET_RECRUITING
Study type: INTERVENTIONAL
Conditions: Biliary Tract Cancer|Breast Cancer|Cervical Cancer|Colon Cancer|Endometrial Cancer|Esophageal Cancer|Gastric Cancer|GastroEsophageal Cancer|Head and Neck Cancer|Hepatocellular Cancer|Non-small Cell Lung Cancer|Pancreatic Cancer|Prostate Cancer|Rectal Cancer|Renal Cancer|Thyroid Cancer
Interventions: DRUG: MDX2001
Sponsor: ModeX Therapeutics, An OPKO Health Company